Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Respiratory mucus is a complex hydrogel primarily composed of water, gel-forming mucoproteins (mucins), and, in pathological states, high concentrations of extracellular DNA (Source: PubMed, PMID: 25108218). Mucins like MUC5AC and MUC5B provide the structural framework through disulfide cross-linking, while extracellular DNA released from infiltrating neutrophils significantly increases the viscosity and elasticity of the mucus (Source: NIH, StatPearls). In chronic respiratory diseases such as cystic fibrosis and chronic obstructive pulmonary disease (COPD), the accumulation of thick, tenacious mucus impairs mucociliary clearance, leading to airway obstruction and recurrent infections (Source: PubMed, PMID: 30243718). Therapeutic strategies target these components to reduce mucus viscosity; for instance, mucolytics like N-acetylcysteine disrupt mucin disulfide bonds, while dornase alfa enzymatically digests the DNA polymers (Source: FDA, Pulmozyme Label). Modulating the physical properties of respiratory mucus is a critical approach to improving lung function and reducing the frequency of pulmonary exacerbations (Source: PubMed, PMID: 29107110).
The mechanism involves the chemical reduction of disulfide bridges between mucin monomers to liquefy mucus, and the enzymatic cleavage of long-chain extracellular DNA into smaller fragments to reduce the viscoelasticity of purulent sputum (Source: StatPearls; PubMed, PMID: 15191020).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Respiratory mucus mucoproteins and extracellular DNA.